Table 6 Methylation, expression analysis of Batch230 focusing only on thyroid-cancer associated genes.
Batch230 | ||||
|---|---|---|---|---|
DMR(FDR) | DE (FDR) | FDRs Combined | Methylation Change (percentage) | |
RAP1GAP | 9.85E-04 | 4.42E-10 | 1.28E-11 | -15.75% |
TIMP3 | - | - | - | -28.98% |
DAPK | 2.61E-03 | 2.38E-06 | 1.23E-07 | 24.97% |
SLC5A8 | - | - | 1.03E-03 | -3.96% |
RARB | - | 7.41E-03 | 2.67E-03 | -3.22% |
TSHR | 2.98E-03 | - | 7.10E-03 | -9.23% |
RASSF6 | 2.59E-04 | - | 1.54E-03 | -37.42% |
CDKN2A | - | 6.15E-05 | 1.22E-04 | 3.38% |
MLH1 | - | - | - | -1.34% |
FN1 | - | 1.86E-09 | 1.27E-09 | -33.47% |
FOXE1 | - | - | - | 1.17% |
HGF | - | - | - | -14.98% |
KRT19 | - | 4.26E-11 | 1.64E-10 | -33.47% |
LGALS3 | 8.55E-03 | 1.27E-13 | 3.85E-14 | -11.78% |
MET | - | 1.13E-17 | 7.35E-18 | -46.44% |
RET | - | 1.22E-03 | 4.33E-04 | -18.49% |
KISS1R | - | 2.84E-05 | 3.77E-05 | -4.81% |
ADAMTS5 | - | 3.53E-03 | 8.71E-04 | 27.62% |
HOXB4 | - | - | - | -3.01% |
TCL1B | 3.50E-03 | - | - | -35.18% |
NOTCH4 | - | - | 9.04E-03 | -12.10% |
RASSF1 | - | - | - | 16.56% |
PPARG | - | 3.04E-03 | 1.21E-03 | -2.92% |
ALK | - | 3.27E-09 | 9.25E-10 | -2.57% |
NTRK3 | - | - | - | -2.15% |